Patents Assigned to EQUALY S.A.
  • CD1 PEPTIDE-EPITOPE FOR USE IN THE TREATMENT OF A DISEASE CAUSED BY AN INTRACELLULAR PATHOGEN
    Publication number: 20230287083
    Abstract: A CD1 peptide-epitope for use in the treatment of a disease caused by an intracellular pathogen, the method for the identification of this CD1 peptide epitope, the pharmaceutical kit comprising this CD1 peptide epitope and the method to treat a patient against a disease caused by an intracellular pathogen or to prevent such infection, based on vaccination with this CD1 peptide-epitope.
    Type: Application
    Filed: July 6, 2021
    Publication date: September 14, 2023
    Applicant: EQUALY S.A.
    Inventor: Jean-Marie SAINT-REMY
  • VACCINE FORMULATIONS
    Publication number: 20230201323
    Abstract: A method to elicit CD4+ T cells with an immune suppressive function towards a given MHC Class II epitope present in a specific target tissue and/or to elicit CD4+ T cells harbouring homeostasis restoration properties for a specific target tissue, based on an MHC Class II epitope modified by the addition of a redox motif, the corresponding modified epitopes, pharmaceutical uses, kits of parts, and gene edition system for use in a patient.
    Type: Application
    Filed: May 31, 2021
    Publication date: June 29, 2023
    Applicant: EQUALY S.A.
    Inventor: Jean-Marie SAINT-REMY
  • VACCINE FORMULATIONS
    Publication number: 20220296704
    Abstract: A pharmaceutically compatible antioxidant for use in the treatment or the prevention of an unwanted immune response, the corresponding pharmaceutical and vaccine compositions, and the corresponding clinical and ex-vivo applications.
    Type: Application
    Filed: June 29, 2020
    Publication date: September 22, 2022
    Applicant: EQUALY S.A.
    Inventor: Jean-Marie SAINT-REMY